NCT03474094: Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy
- State
- Under way
- Phase
- Phase 2
- People
- 62 taking part
- Started
- 1 Aug 2018
- Primary completion
- 30 Dec 2026
- Arms
- pre-operative radiotherapy and atezolizumab, pre-operative atezolizumab and post-operative radiotherapy
- Results
- None posted
- 22 Mar 2018: Trial registered
- 1 Aug 2018: Trial started